Fabior FDA Approval History
FDA Approved: Yes (First approved May 11, 2012)
Brand name: Fabior
Generic name: tazarotene
Dosage form: Foam
Company: Stiefel Laboratories, Inc.
Treatment for: Acne
Fabior (tazarotene) Foam is a retinoid indicated for the topical treatment of acne vulgaris.
Development timeline for Fabior
| Date | Article |
|---|---|
| May 14, 2012 | Approval Stiefel Receives US FDA Approval of Fabior Foam, 0.1% |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
